Cargando…
COVID-19 Incidence in Asymptomatic Cancer Patients Undergoing Chemotherapy
COVID-19 is an infectious disease caused by the virus SARS-CoV-2, which was first described at the end of 2019. Since then, it has affected a growing portion of the world's population because of its high transmissibility. Most patients are asymptomatic or present with mild symptoms, but approxi...
Autores principales: | Monteiro, Claudia, Gomes, Cecília, Marani, Leticia, Colli, Leandro, Calado, Rodrigo T., Figueiredo-Pontes, Lorena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701635/ http://dx.doi.org/10.1182/blood-2021-151772 |
Ejemplares similares
-
Online Patient-Reported Platform Detects Trend of Increased COVID-19 Risk and Severity for Multiple Myeloma Patients on Active Lenalidomide-Based Therapy
por: Liu, Emily I., et al.
Publicado: (2021) -
Impact of the COVID-19 Pandemic on Primary Care Access for Patients with Hematologic Malignancies
por: Ling, Ying, et al.
Publicado: (2021) -
A Prospective Survey to Understand the Preferences and Perspectives of Patients with Hematological Malignancies in a Tertiary Cancer Care Setting in India (CANCOV SURVEY)
por: Sharma, Dr. Neha, et al.
Publicado: (2021) -
Virtual Care during the COVID-19 Pandemic Among Patients with Hematologic Malignancies - a Princess Margaret Cancer Centre Experience
por: Suleman, Adam, et al.
Publicado: (2021) -
Impact of the COVID-19 Pandemic on in-Person Visit Rates Among Patients with Hematologic Malignancies in the United States
por: Goyal, Gaurav, et al.
Publicado: (2021)